sustainably fighting rabies info hub
Did you know that every nine minutes, rabies takes a human life? Find out how we support the elimination of this deadly disease.
Search
2020_San_Diego_Innovation_Prize.pdf
Innovation-Key-facts-Infographic.pdf
boston_innovation_prize_launch event_flyer_2021.pdf
boston_innovation_prize_call_for_entries_flyer_2021.pdf
innovation_prize_ny_flyer.pdf
bdl_heidelberg_innovation_prize.pdf
innovation_prize_ny_flyer.pdf
bdl_heidelberg-innovation-prize.pdf
driving_innovation_cardiovascular _0.pdf
2019_San_Diego_Innovation_Prize_Flyer.pdf
NYC_Innovation_Prize_Flyer_2019_06_11.pdf
Boehringer Ingelheim invests in precision cancer treatments
Boehringer Ingelheim Venture Fund invests in Synthetica as part of its commitment to advancing innovative, next-generation cancer therapies
Europe needs a vibrant research eco-system
At this week's EFPIA Days in Brussels, stakeholders will discuss how to re-establish a research-friendly eco-system in Europe.
Pioneering for progress in generalized pustular psoriasis
An event, bringing together 170 delegates from across the world to strive for excellence in care of GPP
The Research Process
The Research Process
H5N1: Bird flu again. What’s different now?
H5N1: how is avian influenza now? The virus known for affecting wild & domestic birds has been detected in dairy cows in the US. What you need to know.
GARC Louis Nel interview on global rabies control
GARC’s Executive Director Professor Louis Nel shares what it takes to fight rabies.
Immunology
We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in immunology.
Matthias Muenks
Matthias Muenks, Global Engineering Process and Data Manager, speaks about our innovation and culture.
cystic fibrosis phase II trial
The first patient has been enrolled in a phase II trial to evaluate an innovative treatment for cystic fibrosis, inhaled via the Respimat® inhaler
Technologies
We are expanding our global network of technology partners Learn more about partnering with us.
Heart Diseases
Heart Diseases
Making sustainable medicines through eco-design
Our goal is to minimize the environmental footprint of our medicines through integration of eco-design and green chemistry across the entire lifecycle
Our Biotech Story | Bioxcellence | Boehringer Ingelheim
Discover our pioneering history & leadership in biotechnology, driving innovation in biopharmaceutical manufacturing & breakthrough therapies.